68Ga-Fapi PET/CT Versus 18F-FDG PET/CT for Detecting Metastatic Lesions in a Case of Radioiodine-Refractory Differentiated Thyroid Cancer

Hao Fu,Jie Fu,Jingxiong Huang,Yizhen Pang,Haojun Chen
DOI: https://doi.org/10.1097/rlu.0000000000003730
IF: 10.6
2021-01-01
Clinical Nuclear Medicine
Abstract:F-18-FDG PET/CT is a useful imaging modality for detecting disease recurrence and metastases in patients with radioiodine-refractory differentiated thyroid cancer (RAIR-DTC). However, the sensitivity of F-18-FDG PET/CT in RAIR-DTC is not very satisfactory. Ga-68-FAPI is a promising PET tracer that allowed imaging of various types of cancer. In this case, Ga-68-FAPI showed a far better signal-to-background ratio than F-18-FDG for detecting the RAIR-DTC metastatic lesions, especially for detecting the small pulmonary metastases. Therefore, Ga-68-FAPI may be a promising alternative to F-18-FDG for detecting tumor recurrence and metastases in RAIR-DTC. It could also be used for guiding FAP-targeted radionuclide therapy.
What problem does this paper attempt to address?